|
ESRP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.71740000010479E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.52544999999504E-05 |
| Normal-vs-Stage2 |
1.054210E-02 |
| Normal-vs-Stage3 |
4.12309999475724E-08 |
| Normal-vs-Stage4 |
2.04160022221345E-10 |
| Stage1-vs-Stage2 |
8.165800E-01 |
| Stage1-vs-Stage3 |
2.177800E-02 |
| Stage1-vs-Stage4 |
3.81700000000595E-05 |
| Stage2-vs-Stage3 |
2.699200E-01 |
| Stage2-vs-Stage4 |
3.206300E-02 |
| Stage3-vs-Stage4 |
8.669600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.90660000407317E-08 |
| Normal-vs-AfricanAmerican |
2.939200E-03 |
| Normal-vs-Asian |
4.092400E-01 |
| Caucasian-vs-AfricanAmerican |
7.510200E-02 |
| Caucasian-vs-Asian |
3.924000E-01 |
| AfricanAmerican-vs-Asian |
8.392400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.33319999987103E-07 |
| Normal-vs-Female |
3.237800E-03 |
| Male-vs-Female |
5.772600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.004680E-04 |
| Normal-vs-Extreme_Weight |
1.75809999891641E-08 |
| Normal-vs-Obese |
1.60835999999387E-05 |
| Normal-vs-Extreme_Obese |
4.046800E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.715200E-01 |
| Normal_Weight-vs-Obese |
9.969800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.663800E-01 |
| Extreme_Weight-vs-Obese |
5.589200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.083400E-01 |
| Obese-vs-Extreme_Obese |
7.094600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.425500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.70480000005746E-07 |
| Normal-vs-Age(61-80Yrs) |
2.43549999999759E-05 |
| Normal-vs-Age(81-100Yrs) |
1.642479999997E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.154800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.886800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.144400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.447600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.007800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.042650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.17630000021174E-07 |
| Normal-VS-Type2 PRCC |
8.38729996566201E-09 |
| Normal-VS-KIRP CIMP |
7.767800E-02 |
| Normal-VS-Unclassified PRCC |
1.52070000003501E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.205500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.472000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.094170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.036200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.121400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.594400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.60420000008921E-08 |
| Normal-vs-N1 |
1.413880E-04 |
| Normal-vs-N2 |
1.587830E-04 |
| N0-vs-N1 |
9.994000E-01 |
| N0-vs-N2 |
7.537900E-03 |
| N1-vs-N2 |
5.107900E-02 |
|
|
